1. Home
  2. BHVN vs MUX Comparison

BHVN vs MUX Comparison

Compare BHVN & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • MUX
  • Stock Information
  • Founded
  • BHVN 2013
  • MUX 1979
  • Country
  • BHVN United States
  • MUX Canada
  • Employees
  • BHVN N/A
  • MUX N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • MUX Precious Metals
  • Sector
  • BHVN Health Care
  • MUX Basic Materials
  • Exchange
  • BHVN Nasdaq
  • MUX Nasdaq
  • Market Cap
  • BHVN 1.1B
  • MUX 936.8M
  • IPO Year
  • BHVN 2017
  • MUX N/A
  • Fundamental
  • Price
  • BHVN $8.29
  • MUX $17.32
  • Analyst Decision
  • BHVN Strong Buy
  • MUX Strong Buy
  • Analyst Count
  • BHVN 16
  • MUX 4
  • Target Price
  • BHVN $37.07
  • MUX $19.63
  • AVG Volume (30 Days)
  • BHVN 5.6M
  • MUX 1.5M
  • Earning Date
  • BHVN 11-10-2025
  • MUX 11-06-2025
  • Dividend Yield
  • BHVN N/A
  • MUX N/A
  • EPS Growth
  • BHVN N/A
  • MUX N/A
  • EPS
  • BHVN N/A
  • MUX N/A
  • Revenue
  • BHVN N/A
  • MUX $166,453,000.00
  • Revenue This Year
  • BHVN N/A
  • MUX $12.57
  • Revenue Next Year
  • BHVN $2,079.03
  • MUX $23.31
  • P/E Ratio
  • BHVN N/A
  • MUX N/A
  • Revenue Growth
  • BHVN N/A
  • MUX N/A
  • 52 Week Low
  • BHVN $7.48
  • MUX $6.38
  • 52 Week High
  • BHVN $50.40
  • MUX $24.88
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 29.46
  • MUX 47.76
  • Support Level
  • BHVN $7.48
  • MUX $14.93
  • Resistance Level
  • BHVN $8.77
  • MUX $18.15
  • Average True Range (ATR)
  • BHVN 1.12
  • MUX 1.06
  • MACD
  • BHVN -0.71
  • MUX -0.25
  • Stochastic Oscillator
  • BHVN 7.26
  • MUX 50.10

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

Share on Social Networks: